435 Colonizing enteric bacteria are shown to inhibit the antimicrobial process of host cell apoptosis through the action of NleB1, a type III secretion system effector with N-acetylglucosamine transferase activity, which can bind and modify eukaryotic death-domain-containing proteins.
http://www.nature.com/nature/journal/v501/n7466/full/nature12524.html
434 The entire hepatitis C virus life cycle can be recapitulated in an inbred mouse model, allowing preclinical assessment of antiviral therapeutics and vaccines.
http://www.nature.com/nature/journal/v501/n7466/full/nature12427.html
433 Reprogramming microbes to be a pathogen-seeking killer.
http://pubs.acs.org/doi/abs/10.1021/sb400077j
432 Development of Norwalk Virus-Specific Monoclonal Antibodies with Therapeutic Potential for the Treatment of Norwalk Virus Gastroenteritis.
http://jvi.asm.org/content/87/17/9547
431 Passage through the mammalian gut triggers a phenotypic switch that promotes Candida albicans commensalism.
http://www.nature.com/ng/journal/v45/n9/abs/ng.2710.html
430 Gut Bacteria From Thin Humans Can Slim Mice.
http://www.sciencemag.org/content/341/6150/1241214
429 Key tissue targets responsible for anthrax-toxin-induced lethality.
http://www.nature.com/nature/journal/v501/n7465/full/nature12510.html
428 Bacteria activate sensory neurons that modulate pain and inflammation.
http://www.nature.com/nature/journal/v501/n7465/full/nature12479.html
427 A bacterial symbiont is converted from an inedible producer of beneficial molecules into food by a single mutation in the gacA gene.
http://www.pnas.org/content/110/36/14528.abstract
426 Richness of human gut microbiome correlates with metabolic markers.
http://www.nature.com/nature/journal/v500/n7464/full/nature12506.html
|
